HRTIS — Herantis Pharma Oyj Share News
0.000.00%
Brief: Herantis granted almost EUR 3 million government loan for Parkinson study
Brief: Herantis Pharma announces results from phase 2 Cis-UCA Dry Eye study
Brief: Finvector Vision Therapies initiates arbitration proceedings against Herantis Pharma unit
Brief: Herantis Pharma proposes no 2014 dividend
Brief: Herantis Pharma 2014 net loss widens to EUR 8.4 million
Brief: Herantis Pharma starts Phase II study with Cis-UCA Eye Drops
Brief: Herantis Pharma announces FDA clearance of IND for Phase 2 Cis-UCA Eye Drops study